In patients with axial spondyloarthritis (axSpA), chronic back pain typically manifests itself for the first time before the age of 45. Timely referral to rheumatology specialists and close monitoring of symptoms in patients already diagnosed with axSpA help to ensure that patients achieve adequate disease control. Although NSAIDs are still considered first-line therapy, there are now several highly effective treatment alternatives for patients who do not respond adequately.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Renal cell carcinoma
- Lipid management: ESC/EAS guideline update 2025
New recommendations on CVD risk classification, lipid lowering in statin intolerance and hoFH
- Chronically active MS lesions
New paradigm in the diagnosis and treatment of multiple sclerosis
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Participation of the patient
Adherence in psychiatry
- Eosinophilic esophagitis
EoE rarely occurs in isolation
- Lung cancer with EGFR mutation
New perspectives in first-line therapy
- Sleep disorder